Human Endogenous Retroviruses Long Terminal Repeat Methylation, Transcription, and Protein Expression in Human Colon Cancer-Reference-Cited by-同舟云学术

Human Endogenous Retroviruses Long Terminal Repeat Methylation, Transcription, and Protein Expression in Human Colon Cancer

Published:2020-10-27 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Dolci Maria,Favero Chiara,Toumi Wafa,Favi Evaldo,Tarantini Letizia,Signorini Lucia,Basile Giuseppe,Bollati Valentina,D'Alessandro Sarah,Bagnoli Pietro,Ferrante Pasquale,Delbue Serena

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference40 articles.

1. Type W human endogenous retrovirus (HERV-W) integrations and their mobilization by L1 machinery: contribution to the human transcriptome and impact on the host physiopathology;Grandi;Viruses.,2017

2. Classification and characterization of human endogenous retroviruses; mosaic forms are common;Vargiu;Retrovirology.,2016

3. The evolution, distribution and diversity of endogenous retroviruses;Gifford;Virus Genes.,2003

4. The evolutionary dynamics of human endogenous retroviral families;Bannert;Annu Rev Genomics Hum Genet.,2006

5. Expressional activation and functional roles of human endogenous retroviruses in cancers;Zhang;Rev Med Virol.,2019

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Oncoprotein Fra-2 Drives the Activation of Human Endogenous Retrovirus Env Expression in Adult T-Cell Leukemia/Lymphoma (ATLL) Patients;Cells;2024-09-10

2. Mechanistic regulation of HERV activation in tumors and implications for translational research in oncology;Frontiers in Cellular and Infection Microbiology;2024-02-06

3. Human Endogenous Retrovirus-K (HML-2)-Related Genetic Variation: Human Genome Diversity and Disease;Genes;2023-11-28

4. Identification of differentially expressed HERV-K(HML-2) loci in colorectal cancer;Frontiers in Microbiology;2023-06-05

5. Anti-HERV-K Drugs and Vaccines, Possible Therapies against Tumors;Vaccines;2023-03-28